celsus therapeutics-spon adr
(CLTX:Consolidated Issue listed on NASDAQ Capital Market)
Mark S. Cohen
Executive Chairman, Celsus Therapeutics Plc
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Mark Cohen served as the Principal Executive Officer of Celsus Therapeutics Plc. Mr. Cohen has been an Executive Chairman for Celsus Therapeutics Plc. since December 21, 2004. Mr. Cohen is a Senior Partner and Chair of the Life Science Group at Pearl Cohen Zedek Latzer, LLP. He is admitted to the New York and New Jersey bars in the United States and the Israel Bar, and a registered patent attorney in the United States. He received a Bachelor of Arts degree in biochemistry ...
53 Davies streetPhone: 44 20 3318 3004
London, Greater London W1K 5JH
Fax: 44 20 3322 1350
Board Members Memberships*
New York University
Rutgers, The State University of New Jersey
University Of Baltimore School Of Law
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|